Institutional investors purchased a net $251.6 thousand shares of GHDX during the quarter ended December 2015, and now own 95.38% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAKER BROS. ADVISORS LP Bought 220.4 Thousand shares of Genomic Health Inc
MARSHALL WACE LLP Bought 173.2 Thousand shares of Genomic Health Inc
CASDIN CAPITAL LLC Bought 165.0 Thousand shares of Genomic Health Inc